$4.57B
Revenue
$-314.16M
Net Income
74.13%
Gross Margin
-8.60%
Op. Margin
$2.07B
Free Cash Flow
| Breakdown | Q3 2026 (Oct 31, 2025) |
Q2 2026 (Jul 31, 2025) |
Q1 2025 (Apr 30, 2025) |
Q4 2025 (Jan 31, 2025) |
Q3 2025 (Oct 31, 2024) |
Q2 2025 (Jul 31, 2024) |
|---|---|---|---|---|---|---|
| Total Revenue | $1.23B | $1.17B | $1.10B | $1.06B | $1.01B | $963.87M |
| Revenue Growth % (YoY) | 22.2% | 21.3% | nan% | nan% | nan% | nan% |
| Cost of Revenue | $307.81M | $310.28M | $289.14M | $273.99M | $255.09M | $237.40M |
| Gross Profit | $926.44M | $858.67M | $814.29M | $784.55M | $755.09M | $726.47M |
| Gross Margin % | 75.1% | 73.5% | 73.8% | 74.1% | 74.7% | 75.4% |
| Operating Expenses | $995.88M | $971.65M | $938.95M | $869.85M | $810.81M | $712.81M |
| Research & Development | $347.56M | $346.67M | $334.13M | $315.14M | $275.60M | $250.91M |
| Operating Income | $-69.44M | $-112.98M | $-124.66M | $-85.30M | $-55.72M | $13.66M |
| Operating Margin % | -5.6% | -9.7% | -11.3% | -8.1% | -5.5% | 1.4% |
| Interest Expense | $22.50M | $11.25M | $11.25M | - | $22.50M | $11.25M |
| Interest Income | $50.88M | $50.85M | $45.38M | $46.60M | $52.20M | - |
| Income Before Tax | $-23.27M | $-71.67M | $-89.89M | $-46.46M | $-10.54M | $57.60M |
| Income Tax Expense | $10.72M | $5.97M | $21.11M | $46.27M | $6.28M | $10.91M |
| Net Income | $-34.00M | $-77.67M | $-110.21M | $-92.28M | $-16.82M | $47.01M |
| Net Margin % | -2.8% | -6.6% | -10.0% | -8.7% | -1.7% | 4.9% |
| Basic EPS | -0.14 | -0.31 | -0.44 | -0.38 | -0.07 | 0.19 |
| Diluted EPS | -0.14 | -0.31 | -0.44 | -0.37 | -0.07 | 0.19 |
| Basic Shares Outstanding | 251.3M | 249.9M | 248.4M | 733K | 245.5M | 244.1M |
| Diluted Shares Outstanding | 251.3M | 249.9M | 248.4M | -6.0M | 245.5M | 251.3M |
| Breakdown | Q3 2026 (Oct 31, 2025) |
Q2 2026 (Jul 31, 2025) |
Q1 2025 (Apr 30, 2025) |
Q4 2025 (Jan 31, 2025) |
Q3 2025 (Oct 31, 2024) |
Q2 2025 (Jul 31, 2024) |
|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $4.80B | $4.97B | $4.61B | $4.32B | $4.26B | $4.04B |
| Short-term Investments | - | - | - | - | - | - |
| Accounts Receivable | $1.01B | $886.56M | $808.69M | $1.13B | $813.92M | $661.04M |
| Other Current Assets | $306.38M | $302.82M | $296.15M | $314.44M | $203.85M | $230.82M |
| Total Current Assets | $6.52B | $6.53B | $6.07B | $6.11B | $5.57B | $5.18B |
| Property Plant & Equipment | $926.96M | $869.24M | $826.07M | $788.64M | $746.57M | $648.47M |
| Goodwill | $1.35B | $913.33M | $913.28M | $912.80M | $722.02M | $722.00M |
| Intangible Assets | $144.41M | $117.86M | $125.49M | $133.11M | $109.35M | $115.69M |
| Other Non-current Assets | $316.86M | $201.11M | $178.15M | $137.46M | $96.39M | $88.99M |
| Total Assets | $9.97B | $9.29B | $8.72B | $8.70B | $7.78B | $7.20B |
| Accounts Payable | $131.60M | $120.55M | $16.40M | $130.89M | $79.21M | $21.07M |
| Accrued Liabilities | $190.01M | $210.53M | $166.77M | $191.35M | $176.60M | $101.30M |
| Deferred Revenue | $2.85B | $2.78B | $2.75B | $2.73B | $2.36B | $2.35B |
| Other Current Liabilities | $53.22M | $51.28M | $53.65M | $72.75M | $40.76M | $35.03M |
| Total Current Liabilities | $3.60B | $3.48B | $3.28B | $3.46B | $3.00B | $2.73B |
| Long-term Debt | $745.10M | $744.73M | $744.36M | $743.98M | $743.61M | $743.24M |
| Other Non-current Liabilities | $292.56M | $166.90M | $149.12M | $150.85M | $77.41M | $63.89M |
| Total Liabilities | $5.91B | $5.49B | $5.23B | $5.38B | $4.69B | $4.31B |
| Common Stock | $126.00K | $125.00K | $125.00K | $124.00K | $124.00K | $123.00K |
| Retained Earnings | $-1.30B | $-1.27B | $-1.19B | $-1.08B | $-985.83M | $-969.00M |
| Total Stockholders Equity | $4.02B | $3.76B | $3.45B | $3.28B | $3.06B | $2.85B |
| Total Liabilities & Equity | $9.97B | $9.29B | $8.72B | $8.70B | $7.78B | $7.20B |
| Breakdown | Q3 2026 (Oct 31, 2025) |
Q2 2026 (Jul 31, 2025) |
Q1 2025 (Apr 30, 2025) |
Q4 2025 (Jan 31, 2025) |
Q3 2025 (Oct 31, 2024) |
Q2 2025 (Jul 31, 2024) |
|---|---|---|---|---|---|---|
| Net Income | $-34.00M | $-187.88M | $-110.21M | $-92.28M | $73.01M | $89.83M |
| Stock-based Compensation | $822.73M | $540.76M | $253.60M | $272.53M | $592.89M | $384.00M |
| Deferred Income Tax | $-5.36M | $-2.32M | $-1.68M | $-7.78M | $-2.12M | $-1.93M |
| Change in Receivables | $-116.20M | $-242.01M | $-319.87M | $313.40M | $-39.18M | $-192.06M |
| Change in Payables | $-9.63M | $-13.31M | $-83.23M | $50.84M | $34.10M | $-72.00K |
| Operating Cash Flow | $1.11B | $716.94M | $384.11M | $345.72M | $1.04B | $709.87M |
| Capital Expenditure | $199.64M | $116.25M | $85.75M | $87.21M | $167.64M | $88.94M |
| Acquisitions | $380.91M | - | - | $213.88M | $96.38M | $96.38M |
| Investing Cash Flow | $-641.50M | $-150.61M | $-101.83M | $-325.02M | $-211.57M | $-105.99M |
| Financing Cash Flow | $81.09M | $76.32M | $2.13M | $46.39M | $60.82M | $59.98M |
| Net Change in Cash | $561.39M | $649.25M | $290.96M | $62.45M | $884.62M | $662.82M |
SEC Filing Format - Data shown as it appears in the Q3 2026 (10-Q) filing
Period ended: Oct 31, 2025
Condensed Consolidated Statements of Operations
| Description | Oct 31, 2025 | Oct 31, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Total Revenue | $1.23B | $1.01B | $3.51B | $2.90B |
| Cost of Revenue | $307.81M | $255.09M | $907.23M | $717.49M |
| Gross Profit | $926.44M | $755.09M | $2.60B | $2.18B |
| Operating Expenses | $995.88M | $810.81M | $2.91B | $2.21B |
| Research & Development | $347.56M | $275.60M | $1.03B | $761.76M |
| Operating Income | $-69.44M | $-55.72M | $-307.08M | $-35.13M |
| Interest Expense | $6.93M | $6.59M | $22.50M | $22.50M |
| Interest Income | $50.88M | $52.20M | $147.11M | $149.58M |
| Income Before Tax | $-23.27M | $-10.54M | $-184.83M | $101.00M |
| Income Tax Expense | $10.72M | $6.28M | $37.80M | $24.86M |
| Net Income | $-34.00M | $-16.82M | $-221.88M | $73.01M |
| Basic EPS | -0.14 | -0.07 | -0.89 | 0.30 |
| Diluted EPS | -0.14 | -0.07 | -0.89 | 0.29 |
| Basic Shares Outstanding | $251.33M | $245.54M | $249.91M | $244.02M |
| Diluted Shares Outstanding | $251.33M | $245.54M | $249.91M | $250.75M |
Condensed Consolidated Balance Sheets
| Description | Oct 31, 2025 | Jan 31, 2025 |
|---|---|---|
| Cash & Cash Equivalents | $4.80B | $4.32B |
| Accounts Receivable | $1.01B | $1.13B |
| Other Current Assets | $306.38M | $314.44M |
| Total Current Assets | $6.52B | $6.11B |
| Property Plant & Equipment | $926.96M | $788.64M |
| Goodwill | $1.35B | $912.80M |
| Intangible Assets | $144.41M | $133.11M |
| Other Non-current Assets | $316.86M | $137.46M |
| Total Assets | $9.97B | $8.70B |
| Accounts Payable | $131.60M | $130.89M |
| Accrued Liabilities | $190.01M | $191.35M |
| Deferred Revenue | $2.85B | $2.73B |
| Other Current Liabilities | $53.22M | $72.75M |
| Total Current Liabilities | $3.60B | $3.46B |
| Long-term Debt | $745.10M | $743.98M |
| Other Non-current Liabilities | $292.56M | $150.85M |
| Total Liabilities | $5.91B | $5.38B |
| Common Stock | $126.00K | $124.00K |
| Retained Earnings | $-1.30B | $-1.08B |
| Total Stockholders Equity | $4.02B | $3.28B |
| Total Liabilities & Equity | $9.97B | $8.70B |
Condensed Consolidated Statements of Cash Flows
| Description | Oct 31, 2025 | Oct 31, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $-34.00M | $-16.82M | $-221.88M | $73.01M |
| Stock-based Compensation | - | - | $822.73M | $592.89M |
| Deferred Income Tax | - | - | $-5.36M | $-2.12M |
| Change in Receivables | - | - | $-116.20M | $-39.18M |
| Change in Payables | - | - | $-9.63M | $34.10M |
| Operating Cash Flow | - | - | $1.11B | $1.04B |
| Capital Expenditure | - | - | $199.64M | $167.64M |
| Acquisitions | - | - | $380.91M | $96.38M |
| Investing Cash Flow | - | - | $-641.50M | $-211.57M |
| Financing Cash Flow | - | - | $81.09M | $60.82M |
| Net Change in Cash | - | - | $561.39M | $884.62M |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.
Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.